请您收藏——美国内分泌医师协会和美国内分泌学会颁布血脂管理指南
发布时间：2018-12-15 01:06
【摘要】：正近日,美国内分泌医师协会(AACE)和美国内分泌学会(ACE)联合颁布血脂管理指南,重拾了低密度脂蛋白胆固醇(LDL-C)目标值,对动脉粥样硬化性心血管疾病(ASCVD)不同风险的患者设立不同的降脂目标值。极端风险:包括(1)LDL-C70 mg/dl后仍有进展性ASCVD(包括不稳定型心绞痛)的患者;(2)确诊心血管病的糖尿病、3/4期慢性肾
[Abstract]:Recently, the American Association of Endocrinologists (AACE) and the American Endocrine Society (ACE) jointly issued guidelines for the management of blood lipids, regaining the target value of low density lipoprotein cholesterol (LDL-C). Different lipid lowering targets were established for patients with different risk of (ASCVD) for atherosclerotic cardiovascular disease. Extreme risk: (1) patients with progressive ASCVD (including unstable angina pectoris) after LDL-C70 mg/dl; (2) diabetes with confirmed cardiovascular disease, stage 3 / 4 chronic kidney disease
【分类号】：R54
，
本文编号：2379656
[Abstract]:Recently, the American Association of Endocrinologists (AACE) and the American Endocrine Society (ACE) jointly issued guidelines for the management of blood lipids, regaining the target value of low density lipoprotein cholesterol (LDL-C). Different lipid lowering targets were established for patients with different risk of (ASCVD) for atherosclerotic cardiovascular disease. Extreme risk: (1) patients with progressive ASCVD (including unstable angina pectoris) after LDL-C70 mg/dl; (2) diabetes with confirmed cardiovascular disease, stage 3 / 4 chronic kidney disease
【分类号】：R54
，
本文编号：2379656
本文链接：https://www.wllwen.com/yixuelunwen/xxg/2379656.html
最近更新
教材专著
